24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
Lesch-Nyhan syndrome (LNS) is a rare genetic disorder affecting males, characterized by motor difficulties, cognitive impairment, and self-injurious behavior due to a deficiency in the HPRT enzyme. Learn about its causes, symptoms, diagnosis, and management strategies.

Lesch-Nyhan syndrome (LNS) is a rare genetic disorder that affects how the body processes certain chemicals called purines. This leads to a buildup of uric acid and a deficiency in a crucial enzyme called hypoxanthine-guanine phosphoribosyltransferase (HPRT). Because the genetic mutation responsible for LNS is located on the X chromosome, the syndrome is almost exclusively diagnosed in males. While there is no cure for LNS, comprehensive management strategies can significantly help in alleviating symptoms and improving the quality of life for affected individuals.
Lesch-Nyhan syndrome is an X-linked recessive genetic disorder. This means that the gene mutation responsible for the syndrome is located on the X chromosome. Males have one X and one Y chromosome (XY), while females have two X chromosomes (XX).
How it's Inherited:
The mutation in the HPRT-1 gene prevents the body from producing sufficient amounts of the HPRT enzyme. This enzyme is vital for breaking down purines, which are essential components of DNA and RNA. Without enough HPRT, purines accumulate, leading to high levels of uric acid in the blood and urine. This enzyme deficiency also affects the levels of dopamine, a critical neurotransmitter involved in motor control and mood.
Symptoms of Lesch-Nyhan syndrome typically begin to appear in infancy, often between 4 to 6 months of age. While some babies may not show signs at birth, the characteristic features of LNS usually become evident as the child grows.
Diagnosing Lesch-Nyhan syndrome involves a combination of clinical observation and laboratory tests. Early diagnosis is crucial for initiating management and support.
Currently, there is no cure for Lesch-Nyhan syndrome. However, a multidisciplinary approach to treatment and management can significantly help in controlling symptoms, preventing complications, and enhancing the overall well-being of the individual.
As Lesch-Nyhan syndrome is a genetic disorder, primary prevention in the sense of stopping it from occurring is not possible. However, for families with a known history of LNS, genetic counseling and prenatal diagnosis can help in making informed decisions about family planning.
If you notice any signs of developmental delays, unusual involuntary movements, or behavioral issues like self-biting in an infant or child, it is essential to consult a pediatrician or a genetic specialist immediately. Early detection and intervention are key to managing Lesch-Nyhan syndrome effectively and ensuring the best possible outcomes for the child.
Key indicators for seeking medical advice include:
Lesch-Nyhan syndrome presents significant challenges, but with a dedicated medical team, supportive therapies, and a strong family support system, individuals with LNS can lead fulfilling lives. Advances in understanding and managing the condition continue to offer hope for improved care.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026